Multi-strain probiotics obtained from the human gut have shown promising effects in reducing irritable bowel syndrome (IBS) disease severity, and should be further studied as a potential treatment for the condition, say Korean researchers.
Consuming a prebiotic agave fructan jelly could reduce visceral hypersensitivity with short-chain fatty acids, attenuate anxiety and modulate brain activity in irritable bowel syndrome patients with constipation, according to a recent study. The findings...
Istanbul-based Enbiosis Biotechnologies presented its novel microbiome modulation research last week at Probiota Americas after taking top honors as the conference’s Scientific Frontiers winner.
A meta-analysis of published evidence upholds the efficacy of endogenous melatonin to improve irritable bowel syndrome (IBS) severity in diagnosed patients.
A probiotic strain marketed by Lallemand Health Solutions has been granted new health claims related to Irritable Bowel Syndrome (IBS) by Canadian health authority Health Canada.
Vitamin D supplements could help to ease the symptoms of Irritable Bowel Syndrome (IBS) that include bloating, stomach cramps and constipation, a UK review concludes.
A new proprietary method to deliver the Indian botanical extract Boswellia, could boost bioavailability and help manage the symptoms of irritable bowel syndrome (IBS), finds a study by Italian botanical player Indena.
Probiotics could help relieve symptoms of depression in addition to aiding gastrointestinal upsets, according to new Canadian research backed by Nestlé.
Supplements containing Lesaffre Human Care’s ibSium (Saccharomyces cerevisiae CNCM I-3856) may improve gastrointestinal symptoms in people with Irritable Bowel Syndrome (IBS).
New 'gummy' supplement sold out in less than 48 hours
Gut bacteria appears to alter intestinal as well as behavioural patterns in irritable bowel syndrome (IBS) patients in a discovery that points to the strength of microbiota-directed therapies.
A brain-to-gut pathway, where neurological symptoms begin first, may explain why higher levels of anxiety and depression are predictors of developing gastrointestinal disorders, a study has determined.
The majority of people living with Irritable Bowel Syndrome (IBS) could well be deficient in vitamin D, severely affecting their quality of life, a study has found.
Daily intake of Saccharomyces cerevisiae CNCM I-3856 may improve symptoms of Irritable Bowel Syndrome with constipation (IBS-C), says a new study from Lesaffre Human Care.
Lesaffre Human Care, the northern France-headquartered manufacturer of bacteria-based health ingredients, has received health claims approval from the Canadian Health Authorities (CHA) for its product Ibsium, which helps to relieve the symptoms associated...
Dispatches from the International Yakult Symposium
Probiotics are yet to win a health claim in the European Union but they continue to receive backing by various bodies for gastrointestinal issues like diarrhoea.
Doctors are now showing interest in Symprove’s non-dairy multi-strain probiotic for irritable bowel syndrome (IBS) treatment, but it took a published medical paper to get their attention, says the company chairman.
Dispatches from the IPA World Congress in Athens, Greece
Evidence is building that links the gut microbiome and brain function and ‘psychobiotics’ are at the heart of that, says a leading Irish researcher working in the field for more than five years.
Dispatches from the IPA World Congress in Athens, Greece
The EU’s central food science agency will next month open a consultation on immune and gut health that will inform a revised guidance that could come before year’s end and may appease sector anxiety.
A combination of six probiotic species may relieve the symptoms of irritable bowel syndrome (IBS), say results of a randomized, double-blind, placebo-controlled trial.
An extract of kiwifruit containing Zyactinase called Kivia may enhance bowel movement frequency and improve other symptoms of occasional constipation, say new data from a randomized clinical trial.
Consumption of a probiotic containing functional food product has no clinical benefits for people with irritable bowel syndrome (IBS) when compared to a placebo treatment, according to new clinical trial data.
Research backing the gastrointestinal potential of a multi-strain probiotic-fibre product is being presented at United European Gastroenterology Congress in Amsterdam today – a rare speaking opportunity at a medical-focused event with 12,000 attendees.
Clinical data from King’s College in the UK has shown significant Irritable Bowel Syndrome (IBS) reduction for a proprietary probiotic-fibre blend offered by UK start-up, Symprove.
Swedish probiotics supplier Probi has announced an alliance with an unnamed “major multinational” food company that will assist it in its quest to win the first probiotic health claim in the European Union.
UK firm Probiotics International (Protexin) has acquired fellow UK digestive products maker, The Healthy Bowels Company, in an undisclosed deal that sees Protexin gain control of €2m+ pre-probiotic combination brand, Lepicol.
The UK company behind a high pH, electrolysed water product says it fully expected the advertising watchdog to rule against its cancer, ageing and other claims, and will appeal.
Daily supplements of two probiotic strains may ease symptoms of bloating in people with bowel disorders, say researchers from the University of North Carolina at Chapel Hill and Danisco USA.
French Canadian company Institut Rosell has agreed a seven-year partnership with Swedish probiotic research and the development firm Probi covering dietary supplements based on its bacterial Lp299v strain.
The human nutrition division of French yeast specialist Lesaffre has launched what it says is only the second known probiotic yeast, and the first to directly target Irritable Bowel Syndrome (IBS).
A ‘high-potency’ lactic acid bacteria supplement may ease the symptoms of irritable bowel syndrome (IBS) in children, says a new study that echoes results from adult studies.
The UK Advertising Standards Authority (ASA) has ruled against press adverts promoting the bowel health potential of probiotic and fibre-containing food supplements due to a lack of scientific backing.
Daily supplements of Lactobacillus plantarum 299v may reduce the symptoms of Irritable Bowel Syndrome (IBS) like abdominal pain and bloating, says new research from Institut Rosell.
Daily supplements of St John’s wort are not effective for improving symptoms of irritable bowel syndrome (IBS), according to a new study from the Mayo Clinic.
Probiotics should be considered as living drugs rather than “simple good bacteria” in order to become effective treatment options for IBS, according to Joseph Haddad, medical director of Institut Rosell-Lallemand.
Adding soluble fibre to the diet may improve symptoms associated with irritable bowel syndrome, but insoluble fibre may worsen the effects, says a new study.
Most Australian consumers are still not ready to believe the claims made by probiotic products, despite a steady and growing interest in their value for improving digestive health, according to Datamonitor.
Increasing knowledge of how the gut and brain is opening up the possibilities for probiotics. At the 5th International Yakult Symposium in Amsterdam, Stephen Daniells met Professor John Bienenstock from McMaster University to find out where the current...
Finnish dairy and ingredients supplier, Valio, will submit data it believes may alter the negative opinion for a probiotic-related, gastro-intestinal health claim delivered by the European Food Safety Authority (EFSA) recently.
A health claim submission linking probiotic consumption and gastro-intestinal health has not been supported after scientific assessment by the European Food Safety Authority (EFSA).
Institut Rosell-Lallemand has teamed up with Ranbaxy and Aristo
Pharmaceuticals to distribute supplements based on a probiotic
bacteria, which will see it become available in the massive Indian
market for Irritable Bowel Syndrome.
Dietary supplements based on the Lactobacillus plantarum
299v probiotic by Institut Rosell-Lallemand have expanded
further into Europe - a move which shows the increasing popularity
of the friendly bacteria.
A unique technique to extract fucoidans from sea weed through a
coldwater extraction process has been trademarked by Marinova,
allowing the company to protect its processing capability and gain
further leverage in the nutraceutical...
Korean company Cell Biotech is establishing operations in Denmark
to expand use of its dual-coated probiotics in Europe market -
particularly in new, non-dairy food categories.
Marinova's new fucoidan facility in Hobart, Tasmania, is on
schedule to commence operations from next month, offering fucoidans
from a broader range of microalgae species for nutraceutical and
cosmetics use.
Institut Rosell has obtained more evidence that its Lacidofil
probiotic, composed of two strains of live lactic acid bacteria,
may help alleviate the symptoms of irritable bowel syndrome (IBS),
when used in conjunction with conventional...
